Abstract-We have previously reported that leukemia inhibitory factor (LIF) gradually increased cardiac L-type Ca 2ϩ channel current (I CaL ), which peaked at 15 minutes in both adult and neonatal rat cardiomyocytes, and this increase was blocked by the mitogen-activated protein kinase kinase inhibitor PD98059. This study investigated the molecular basis of LIF-induced augmentation of I CaL in rodent cardiomyocytes. LIF induced phosphorylation of a serine residue in the ␣ 1c subunit (Ca v 1.2) of L-type Ca 2ϩ channels in cultured rat cardiomyocytes, and this phosphorylation was inhibited by PD98059. When constructs encoding either a wild-type or a carboxyl-terminal-truncated rabbit Ca v 1.2 subunit were transfected into HEK293 cells, LIF induced phosphorylation of the resultant wild-type protein but not the mutant protein. Cotransfection of constitutively active mitogen-activated protein kinase kinase also resulted in phosphorylation of the Ca v 1.2 subunit in the absence of LIF stimulation. In in-gel kinase assays, extracellular signal-regulated kinase phosphorylated a glutathione S-transferase fusion protein of the carboxyl-terminal region of Ca v 1.2 (residues 1700 through 1923), which contains the consensus sequence Pro-Leu-Ser-Pro. A point mutation within this consensus sequence, which results in a substitution of alanine for serine at residue 1829 (S1829A), was sufficient to abolish the LIF-induced phosphorylation. 
T he cardiac L-type Ca 2ϩ channel is the predominant ion channel within the heart, with each cardiomyocyte expressing Ϸ30 000 copies. 1 Cardiac L-type Ca 2ϩ channels play essential roles in cardiac excitability, in coupling excitation to contraction, and in arrhythmogenesis. The channel is composed of four subunits, ␣ 1 , ␣ 2 , ␤ 2 , and ␦, and some channel functions are regulated by phosphorylation of the ␣ 1c subunit (Ca v 1.2). 2 Protein kinase A (PKA) has been shown to phosphorylate the serine residue at the carboxyl end of Ca v 1.2, 3, 4 and protein kinase C (PKC) may phosphorylate Ca v 1.2 at the amino terminal. 5 These findings suggest that phosphorylation of the intracellular domain of the cardiac L-type Ca 2ϩ channel may be the critical mechanism for modulating its current.
Leukemia inhibitory factor (LIF) is a member of the interleukin-6 family and has a potent hypertrophic effect on cardiomyocytes. 6 We and others have demonstrated that JAK/STAT, 6, 7 mitogen-activated protein kinase, 8 phosphatidylinositol 3 kinase, 9 and calmodulin-dependent kinase 10 lie downstream of gp130 in cardiomyocytes and that these pathways play important roles in mediating cardiac hypertrophy. While investigating the molecular mechanism of LIFinduced cardiac hypertrophy, we found that this cytokine increases the L-type Ca 2ϩ current (I CaL ) in cardiomyocytes. 11 Although the molecular mechanisms by which LIF stimulates I CaL remains unknown, we have shown it to be independent of PKA and PKC and have shown that the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 specifically inhibits the LIF-induced amplification of I CaL . We also identified two extracellular signal-regulated kinase (ERK) consensus sequences (Pro-X-Ser and Thr-Pro) at the carboxyl end of Ca v 1.2 and showed that they are conserved among different species (human, rat, mouse, and rabbit). Based on these findings, we investigated whether LIF can induce phosphorylation of Ca v 1.2 via the ERK1/2 pathway and whether this phosphorylation increases I Ca,L in cardiomyocytes.
Materials and Methods

Materials
Anticardiac L-type Ca 2ϩ channel ␣ 1c subunit (Ca v 1.2), anti-phospho-ERK1/2, and anti-ERK2 antibodies were purchased from Alomone Labs (Jerusalem, Israel), New England Biolabs (Beverly, Mass), and Santa Cruz Biotechnology (Santa Cruz, Calif), respectively. Angiotensin II and recombinant rat LIF were purchased from Sigma (St Louis, Mo) and Genzyme (Cambridge, Mass), respectively.
Cell Culture
Primary cultures of 1-day-old neonatal and adult Wistar rat cardiomyocytes were prepared as described previously. 6, 11 HEK293 and rat aortic smooth muscle cells (P7-10) were cultured as described previously. [12] [13] [14] 
Preparation of Cell Lysates and Immunoprecipitation
Cells were harvested in a lysis buffer containing 10 mmol/L HEPES, pH 7.4, 50 mmol/L sodium pyrophosphate, 50 mmol/L NaF, 50 mmol/L NaCl, 5 mmol/L EDTA, 5 mmol/L EGTA, 100 mol/L Na 3 VO 4 , 0.5 mmol/L PMSF, 10 g/mL leupeptin, and 0.1% Triton X-100. 12, 14 The cells were thawed on ice, scraped, sonicated, and centrifuged at 14 000g at 4°C for 30 minutes. Lysates were immunoprecipitated using anti-Ca v 1.2 polyclonal antibody (Alomone) at 4°C for 12 §, followed by protein G-Sepharose (Sigma) for 1 hour. Immunoprecipitates were used immediately or stored at Ϫ80°C. Western blot analysis was performed as described previously, 12 and the blots were detected by ECL (Amersham Biosciences).
Preparation of Glutathione S-Transferase Fusion Proteins
Three constructs encoding different regions of the C-terminal cytoplasmic domain of rabbit Ca v 1.2 15 (residues 1472 through 2171) were prepared by polymerase chain reaction (PCR). The first spanned residues 1472 through 1699, the second spanned residues 1700 through 1923 (containing the ERK1/2 consensus sequence Pro-Leu-Ser-Pro), and the third spanned residues 1924 through 2171 (containing the ERK1/2 consensus sequence Pro-Ala-Thr-Pro). The orientation and reading frames of all constructs were confirmed by sequencing. The primers used to amplify each region were designed so that PCR products contained a 5Ј BamHI restriction site and a 3Ј EcoRI restriction site. Each PCR product was cloned into pGEX-3X. After transformation with glutathione S-transferase (GST)-Ca v 1.2 constructs, cultures of Escherichia coli (BL21) were grown to the sub-log phase, and fusion proteins were induced by exposure to 0.1 mmol/L isopropyl-ß-D-thiogalactopyranoside (Sigma) for 3 hours. Cells were collected, sonicated, and centrifuged, and supernatants were incubated with glutathione-agarose beads (Sigma) overnight at 4°C. Bound fusion proteins were washed extensively and then eluted with 20 mmol/L reduced glutathione, 100 mmol/L Tris-HCl (pH 7.4), and 100 mmol/L NaCl. Protein concentrations were estimated by Coomassie blue staining of the SDS-PAGE separated proteins. 13 
In Vivo Phosphate Labeling and Phospho-Amino Acid Analysis
Cells were metabolically labeled with 32 P-orthophosphate (250 Ci/mL) using previously published protocols. 14 Before immunoprecipitation, the samples were equilibrated to contain an equal amount of protein. The Ca v 1.2 subunit from cardiac L-type Ca 2ϩ channels was immunoprecipitated and separated by 5% SDS-PAGE. The immunoprecipitates for the phospho-amino acid analysis were incubated with 6N HCl at 106°C for 60 minutes, and the radioactive phospho-amino acids obtained were then applied to a thin-layer chromatography plate. The amino acids were separated by electrophoresis (1000 V for 30 minutes; 10% acetic acid, 1% pyridine in water, pH 3.3). 16 The plates were exposed to radiograph film, and the location of the nonradioactive and radioactive phospho-amino acids was detected by ninhydrin reaction and by radiograph film, respectively.
Construction of Mutant Plasmids and Cell Transfection
A deletion mutant of Ca v 1.2 was prepared by truncation of the C-terminal amino acids (from 1812 through 2171). A second Ca v 1.2 mutant was prepared with a serine to alanine substitution at position 1829. For transient transfections, HEK293 cells at 50% to 60% confluence were seeded onto 100-mm dishes 24 hours before transfection and then cotransfected with 1.0 g of Ca v 1.2 plasmid, 1.0 g of ␤ 2b plasmid, and 1.0 g of enhanced green fluorescent protein (eGFP) plasmid using an Effecten kit (Qiagen). Successfully transfected cells were then easily identified by their fluorescence. In some experiments, the cells were simultaneously cotransfected with 0.5 g of either a plasmid containing constitutively active MEK or empty vector. After incubation for 24 hours with the DNA-lipid complexes, the serum-containing medium was changed, and the next day the cells were serum deprived by incubation with 1% calf serum for 24 hours and then labeled with 32 P-orthophosphate.
Perforated Patch-Clamp Recording
Perforated patch-clamp recording was performed in GFP-positive HEK293 cells transfected with constructs encoding wild-type or mutated Ca v 1.2 and rabbit ␤ 2b subunits 17 for functional analysis of L-type Ca 2ϩ channels using slight modifications to previously described protocols. 18, 19 The pipette solution contained 170 mmol/L CsCl, 1.1 mmol/L MgCl 2 , 2 mmol/L BaCl 2 , and 5 mmol/L HEPES (adjusted to pH 7.0 with CsOH). Gramicidin was dissolved in DMSO (100 mg/mL) immediately before the experiment and diluted in the pipette solution to a final concentration of 100 g/mL (giving a final DMSO concentration of 0.1%). The extracellular solution was Tyrode's solution, which contained 2 mmol/L BaCl 2 , 140 mmol/L NaCl, 4 mmol/L CsCl, 0.5 mmol/L MgCl 2 , 5 mmol/L HEPES, and 55 mmol/L glucose (pH 7.4). Cells were mounted on a thermocontrolled bath set at 34°C to 34.5°C, and Tyrode's solution containing 1000 U/mL LIF was then bath applied. In this system, the solution in the bath was completely changed 5 to 8 minutes after switching the superfusate.
A pipette resistance of 3 to 4 M⍀ was used. Isolated GFP-positive HEK293 cells were selected for the experiment. The Ba 2ϩ current was initiated using a 15-ms test pulse from Ϫ20 to ϩ10 mV with 10-mV increments and was followed by a 200-ms conditioning prepulse to Ϫ50 mV from the holding potential of Ϫ80 mV to allow the peak inward current at 0 mV for the test potential to be generated. The series resistance during recording was stable at 20 to 25 M⍀. Because of the geometry and small size of the HEK293 cells, the series resistance might not represent cell access resistance. To confirm good voltage clamping, we determined the voltage of the test pulse that generated the peak I CaL and the time to reach the peak current (Ͻ3 ms) from the onset of the test pulse. The I CaL was then elicited every 30 seconds by a train step pulse protocol for 0 mV with the same conditioning pulse. The stability of amplitude of I CaL and the holding current was examined for a few minutes before the administration of LIF. The current-voltage relationship was measured immediately before the train pulse protocol and after the LIF-induced current change was stabilized using the test potential from Ϫ40 to ϩ10 mV under the same conditions.
Statistical Analysis
Values are reported as meanϮSD. The significance of differences between mean values was determined by ANOVA. Statistical comparisons between the control group and the experimental group were made using Bonferroni's tests. Differences were considered statistically significant for values of PϽ0.05. Figure 1 depicts the 2D structure of Ca v 1.2 and of the ␤ 2b subunit of L-type Ca 2ϩ channels. Ca v 1.2 contains two consensus sequences at the C-terminal end that are ERK-specific phosphorylation sites. 19 The Pro-Ala-Thr-Pro sequence is conserved in all species examined to date (human, residues 1998 through 2001; rabbit, residues 1986 through 1989), 20, 21 and the Pro-Leu-Ser-Pro sequence is also conserved in both humans (residues 1797 through 1800) and rabbits (residues 1827 through 1830).
To investigate whether LIF phosphorylates Ca v 1.2 via the MEK/ERK pathway, primary cultured rat cardiomyocytes were metabolically labeled with 32 P orthophosphate and stimulated with LIF (1000 U/mL, 15 minutes). Subsequent phosphorylation of Ca v 1.2 was detected by immunoprecipitation. LIF strongly induced phosphorylation of Ca v 1.2, 4.2Ϯ1.6-fold greater than the control, and this was inhibited by PD98059 (Figure 2 ). Phospho-amino acid analysis confirmed that LIF only phosphorylated the serine residues in Ca v 1.2 ( Figure 3 ).
Constitutively Active MEK Phosphorylates ERK1/2 and Ca v 1.2
To confirm that the MEK/ERK pathway is involved in the phosphorylation of Ca v 1.2, we cotransfected HEK293 cells with constructs encoding wild-type Ca v 1.2 and ␤ 2b subunits and constitutively active MEK1 (ca-MEK1) 22 or vector alone and measured phosphorylation. Western blot analysis using anti-phospho-ERK antibody revealed that ca-MEK1 phosphorylated ERK1/2. Metabolic labeling with 32 Porthophosphate showed that ca-MEK1 also induced phosphorylation of wild-type Ca v 1.2. The intensity of the phosphorylation of Ca v 1.2 was 2.6-fold greater than controls (PϽ0.05, nϭ3) ( Figure 4A ). with LIF. Although the wild-type Ca v 1.2 was phosphorylated 2.9-fold greater than the control (nϭ5, PϽ0.05), the deletion mutant was not phosphorylated by LIF at all (nϭ5, not significant) ( Figure 4B ).
LIF Phosphorylates the
LIF Phosphorylates the Carboxyl-Terminal of Ca v 1.2 From Amino Acids 1812 through 2171
To identify the phosphorylation site, we prepared deleted GST-fusion proteins of Ca v 1.2 as a substrate and performed in-gel kinase assays. The three deleted fusion proteins contained either no ERK1/2 consensus sequences, the Pro-LeuSer-Pro sequence, or the Pro-Ala-Thr-Pro sequence (see also Figure 1 ). Serum-starved primary cultured rat neonatal cardiomyocytes and rat aortic smooth muscle cells were incubated for 15 minutes with LIF and angiotensin II, respectively, and in-gel kinase assays were performed using myelin basic protein (MBP), GST, or deleted Ca v 1.2 GST-fusion proteins. ERK1/2, which was activated by LIF, phosphorylated the MBP and the protein containing the Pro-Leu-SerPro consensus sequence, and this phosphorylation was blocked by preincubation with PD98059 ( Figure 5 ). These findings indicate that activated ERK1/2 can phosphorylate the carboxyl terminal of Ca v 1.2 between amino acids 1700 and 1923.
Ca v 1.2 Is Specifically Phosphorylated by LIF at Serine 1829
To confirm that the LIF-induced phosphorylation of the carboxyl-terminal of the L-type Ca 2ϩ channel actually occurred at the ERK target sequence (Pro-Leu-Ser-Pro, 1827 through 1830), we cotransfected HEK293 cells with the ␤ 2b subunit and constructs encoding either the S1829A mutant Ca v 1.2 or wild-type Ca v 1.2. Cells were then metabolically labeled with 32 P-orthophosphate. After treatment with LIF, the wild-type Ca v 1.2 was phosphorylated 2.9-fold over the control, whereas the mutant Ca v 1.2 remained unphosphorylated ( Figure 6 ), indicating that Ca v 1.2 was specifically phosphorylated at serine 1829.
LIF Increased I CaL in the Wild-Type Ca v 1.2 but not in the S1829A Mutant Ca v 1.2
To confirm that the S1829A point mutation in Ca v 1.2 abolished the response to LIF, we measured the peak inward current in HEK293 cells cotransfected with the ␤ 2b subunit and either wild-type or mutant Ca v 1.2. In our preliminary conventional whole-cell patch clamp experiment, the peak inward current varied from 0 to 6 nA in wild-type (nϭ57) and from 0 to 2 nA in mutant (nϭ30) cells, but the difference was not statistically significant. Little or no inward current (Ͻ50 pA) was observed in 10 GFP-positive wild-type cells or in four GFP-positive mutant cells. Although some cells displayed large currents (Ͼ1nA; nϭ2 in wild-type, nϭ1 in mutant), the current density was generally similar between the two groups. In the perforation patch-clamp experiment, the amplitude of the current was stable during the observation period, suggesting no natural run down. The amplitude of the peak current 5 minutes after exposure to LIF increased in the wild-type Ca v 1.2 cells (38Ϯ40%, nϭ7), whereas there was a small decrease in current in mutant cells (Ϫ16Ϯ10%, nϭ7, PϽ0.05 versus wild-type). A representative time course of the increase in I CaL is shown in Figure 7 . The representative original current trace was shown in online Figures 1 and 2 (available in the online data supplement at http://circres.ahajournals.org). Cells transfected with wild-type showed an increase in the amplitude of the current 5 minutes after exposure to LIF that reached a maximum after 20 minutes. Cells transfected with mutant showed a small decrease immediately after the change of solution that was stable for Ͼ30 minutes. Furthermore, extracellular application of 10 mol/L dB-cAMP or 8Br-cAMP did not increased the I CaL in wild-type cells, suggesting there is no PKA pathway to phosphorylate the L-type Ca 2ϩ channel in HEK293 cells (data not shown). These results indicated that the LIF-induced increase in I CaL was mediated by the phosphorylation of serine 1829. 
Discussion
This study investigated the molecular mechanisms of the LIF-induced increase in I CaL . LIF was found to induce specific phosphorylation of serine 1829 of rabbit Ca v 1.2, the ␣ 1c subunit of the cardiac L-type Ca 2ϩ channel. Because LIF failed to induce any increase in current when the subunit contained an S1829A point mutation, we have shown that this phosphorylation event is necessary for the observed increase in I CaL . The serine residue at position 1829 lies within an ERK1/2 consensus phosphorylation sequence and is therefore phosphorylated either by ERK1/2 or kinases activated by ERK1/2. In agreement with a previous study, 23 PKA activation by the cell-permeable cAMP compound failed to increase I CaL in HEK293 cells because of the lack of A-kinase anchoring protein. This also suggests that the LIF-induced increase in I CaL in this system follows a pathway independent of the PKA pathway. Haase and colleagues 26, 27 reported that PKA phosphorylates the ␤ subunit and increases Ca 2ϩ entry in response to ␤-adrenergic stimulation both in vivo and in vitro. Bünemann et al 28 showed that phosphorylation of serine 478 and serine 479 of the ␤ 2 subunit is involved in this PKA-dependent augmentation of I CaL .
This study has identified a novel regulatory mechanism of cardiac I CaL . To our knowledge, this is the first report of ERK1/2 involvement in the regulation of cardiac I CaL . There seem to be several reasons why this involvement has not been previously recognized. After ligand stimulation, PKA, PKC, and protein kinase G are rapidly activated following the rapid increase of the upstream second messengers cAMP, DG, and cGMP. As a result, these kinases can phosphorylate Ca v 1.2 and modulate the I CaL at an early stage, eg, 1 to 5 minutes after the stimulus. By contrast, ERK1/2 is activated through various signaling molecules, such as sos, shc, Grb2, raf1, and MEK, and its activation does not peak until 8 to 15 minutes after the stimulus. The activation by LIF peaked at 15 minutes. In addition, the ERK-mediated increase in I CaL was only Ϸ25% to 30% greater than baseline, far smaller than the increase by PKA. Presumably, this relatively small and slow increase in Ca 2ϩ current caused by ERK or its downstream kinases was easily masked by the other stimuli. For example, endothelin-1 is known to increase I CaL in cardiomyocytes. Because the ET-A receptor is linked to G s /G i /G q , endothelin-1 stimulation rapidly increases cAMP and IP3, resulting in rapid activation of PKA and PKC at as early as 1 to 3 minutes. 29, 30 Endothelin-1 also activates ERK, but its activation peaks at 8 to 10 minutes, 31 and thus the rapid activation of PKA or PKC may mask the ERK-mediated augmentation of I CaL by endothelin-1. By contrast, the signaling pathway via LIF uses raf1/MEK/ERK, JAK/STAT, and phosphatidylinositol 3-kinase/ACT pathways through gp130 and not the PKA or PKC pathways. Presumably we were able to detect ERK1/2-mediated modification of cardiac L-type Ca 2ϩ channels because LIF activates ERK and not PKA or PKC.
ERK1/2 is a ubiquitously expressed member of the mitogen-activated protein kinase family, which is activated in response to a variety of extracellular stimuli. It has been implicated in both growth and apoptosis in the cardiovascular system. The downstream substrates of ERK include other kinases, transcription factors, and membrane receptors and other cell mediators. The only evidence of ERK functioning in the regulation of the activity of membrane ion channels has come from neurological studies. Adams and colleagues 32, 33 reported that the A-type potassium channel Kv4.2 is a substrate for ERK in hippocampal neurons and demonstrated that ERK phosphorylates threonine 602, threonine 607, and serine 616 within the cytoplasmic domain. Shi et al 34 demonstrated that ERK phosphorylates the carboxyl terminal of the ␤ (threonine 613) and ␥ (threonine 623) subunits of the epithelial Na ϩ channel, thereby facilitating their interactions with the ubiquitin ligase Nedd4, which ultimately inhibits channel activity. These findings indicate that the phosphorylation of membrane ion channels by ERK1/2 is perhaps not an uncommon regulatory mechanism. This study is the first to demonstrate involvement of ERK1/2 in modifying cardiac ion channels.
In the present study, the phosphorylation status of the ␤ 2b subunit was not investigated, because preliminary experiments showed that LIF does not cause phosphorylation of this subunit. Our finding that the point mutation of Ca v 1.2 at serine 1829 completely abolishes the increase in I CaL suggests that it is unlikely that phosphorylation of the ␤ 2b subunit plays a critical role in the regulation of the LIF-induced increase in I CaL . Because cardiac L-type Ca 2ϩ channels are critical ion channels in the control of cardiac function, additional investigations are needed to precisely identify all of the regulatory mechanisms involved. 
